Skip to main content
Normal View

Covid-19 Pandemic

Dáil Éireann Debate, Tuesday - 2 November 2021

Tuesday, 2 November 2021

Questions (1022)

Seán Canney

Question:

1022. Deputy Seán Canney asked the Minister for Health the makes of Covid-19 vaccines now available here; and if he will make a statement on the matter. [52947/21]

View answer

Written answers

Ireland is participating in a Procurement Exercise being operated by the European Commission on behalf of Member States to procure suitable, safe and effective vaccines, in sufficient quantities, to combat COVID-19.

Four vaccines have been authorised by the EU to date; Comirnaty (Pfizer/BioNTech), Spikevax (Moderna), Vaxzevria (AstraZeneca) and Janssen.

A number of vaccine candidates are currently under rolling review by the European Medicines Agency (EMA) including NVX-CoV2373 (Novavax), CVnCoV (CureVac) and Sputnik V (Gam-COVID-Vac).

When medicines are under rolling review, the EMA human medicines committee CHMP evaluates clinical trial data as soon as these become available until it decides there is enough evidence for the developer to apply for marketing authorisation

The EMA cannot provide exact timelines as these depend on when developers provide the necessary data for CHMP review. The EMA updates the status of each medicine under rolling review when the developer applies for marketing authorisation.

Question No. 1023 answered with Question No. 777.
Question No. 1024 answered with Question No. 810.
Top
Share